ASURAGEN, INC.

Address

2150 WOODWARD STREET
SUITE 100
AUSTIN, TX, 78744-1038

Information

DUNS: 622988330
# of Employees: 121

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Development of an information-rich assay for C9ORF72 as a test for ALS and FTD

    Amount: $619,938.00

    Project Summary The long term goal of this project is to develop validate and commercialize an assay for improved analysis of C orf a gene on chromosome that is linked to frontotemporal dement ...

    SBIRPhase II2016Department of Health and Human Services
  2. IGF OT IGF BCR ABL RT QPCR TEST FOR IMPROVED MONITORING OF CML

    Amount: $1,489,494.00

    Not Available

    SBIRPhase II2015Department of Health and Human Services
  3. Quantitative Superplexing: Single-tube, many-target qPCR for cancer diagnostics

    Amount: $246,864.00

    DESCRIPTION provided by applicant A novel andquot Superplexandquot RT qPCR strategy will be optimized for the single tube amplification and quantification of targeted panels of fusion transcripts t ...

    SBIRPhase I2015Department of Health and Human Services
  4. Development of a reliable and standardized molecular assay for fragile x protein

    Amount: $225,000.00

    DESCRIPTION provided by applicant The goal of this project is to develop a validated quantitative assay for the fragile X mental retardation protein FMRP to aid in the clinical management of tho ...

    SBIRPhase I2015Department of Health and Human Services
  5. Comprehensive Solution for Transcriptome Profiling of Archived Tissues

    Amount: $225,000.00

    DESCRIPTION (provided by applicant): The overall goal of this proposal is to expand the capability for molecular analyses of formalin fixed paraffin-embedded (FFPE) specimens through the use of whole ...

    SBIRPhase I2014Department of Health and Human Services
  6. Development of an information-rich assay for C9ORF72 as a test for ALS and FTD

    Amount: $222,511.00

    DESCRIPTION (provided by applicant): The long term goal of this project is to develop, validate, and commercialize an assay to improve screening of C9ORF72, a gene on chromosome 9 that is linked to f ...

    SBIRPhase I2014Department of Health and Human Services
  7. Integrated Bioinformatics Analysis Suite for targeted NGS of clinical specimens

    Amount: $1,140,126.00

    DESCRIPTION provided by applicant With the advent of rapid bench top sequencers such as the PGM and MiSeq the potential to transform cancer diagnosis and patient care is great Although sequencing ...

    SBIRPhase II2014Department of Health and Human Services
  8. Development of clinical triage assay for sepsis management in the Emergency Room

    Amount: $314,420.00

    DESCRIPTION (provided by applicant): The overall project objective is to further develop and clinically validate an assay, SeptiCyte(R)Triage, to improve screening and early diagnosis of conditions as ...

    SBIRPhase I2013Department of Health and Human Services
  9. Enabling use of blood spot cards for accurate high throughput Fragile X screening

    Amount: $2,153,865.00

    DESCRIPTION (provided by applicant): The long term goal of this project is to develop accurate, rapid, high throughput and cost-effective screening for fragile X syndrome (FXS) and related disorders. ...

    SBIRPhase II2013Department of Health and Human Services
  10. SBIR TOPIC 315: DEVELOPMENT OF COMPANION DIAGNOSTICS: ENABLING PRECISION MEDICINE

    Amount: $241,044.00

    Asuragen is developing a sensitive, accurate, and reliable test (BCR-ABL1 RT-qPCR Test), for quantification of BCR-ABL1 fusion transcripts to monitor residual disease in patients with chronic myeloid ...

    SBIRPhase I2013Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government